Midcareer Investigator Award in Patient-Oriented Research
以患者为导向的研究中的职业生涯中期研究员奖
基本信息
- 批准号:9108690
- 负责人:
- 金额:$ 17.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-15 至 2021-02-28
- 项目状态:已结题
- 来源:
- 关键词:AreaAwardCaliberCenters for Disease Control and Prevention (U.S.)ChronicCommunicable DiseasesDevelopmentDialysis procedureDisciplineEducational StatusEnvironmentFacultyFoundationsFundingGenotypeGeriatricsGoalsGrantGrowthHemodialysisIndividualInstitutionJournalsLearningLettersLong-Term CareMathematicsMedicineMentorsMentorshipMethodologyMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchNephrologyOrganism StrainsOutpatientsPatientsPilot ProjectsPopulationPositioning AttributePrevention strategyPrincipal InvestigatorPublic Health SchoolsPublishingRandomized Controlled TrialsRecruitment ActivityResearchResearch PersonnelResourcesRiskScienceSecureStructureTimeTrainingTraining ProgramsUnited States Agency for Healthcare Research and QualityUnited States National Institutes of HealthUniversitiesantimicrobialcareercohortdisorder preventioninterestmathematical modelmicrobialmicrobiomemulti-drug resistant pathogennext generation sequencingnovelpatient oriented researchprogramspublic health relevanceskillssuccesstransmission process
项目摘要
DESCRIPTION (provided by applicant): My career goals are to continue as an investigator in patient-oriented research (POR) and to provide mentoring for beginning investigators. My research focuses on the transmission dynamics of multidrug-resistant organisms (MDRO) among hospitalized patients, residents of long term care facilities, and the chronic hemodialysis population. My research has identified key and novel aspects of MDRO transmission and has quantified the most effective prevention strategies aimed at reducing their spread. Methodologies of my POR include large cohort and randomized controlled trials, genotyping of MDRO strains and mathematical modeling. Over the past years, I have built a successful independent research program and have secured National Institute of Health (NIH), Centers for Disease Control and Prevention, and National Science Foundation funding. I have also mentored numerous fellows and junior faculty, who under my mentorship, have obtained their own funding, published in leading journals and have gone on to become independent investigators and obtain academic faculty positions. Since my research crosses several disciplines, I have mentored trainees in a variety of subspecialties, including infectious diseases nephrology, geriatrics and mathematics. This is an optimal time in my career for a K24 award as I have an active research program that focuses on the development and implementation of antimicrobial stewardship programs in long term care facilities and out-patient dialysis units. This research will allow me to provide ample opportunities for trainees to perform research. I have also recently expanded my research area to the analyses of the microbiome and the identification of specific microbial signatures that increase the risk of MDRO acquisition, and have recently submitted an R01 with Dr. Martin Blaser (co-principal investigator), who is dedicated to providing his senior mentorship in this new area of my research. The K24 will allow me the time required to dedicate myself to learning this new field, and the ongoing growth of my research agenda. Lastly, this K24 will also allow me to have protected time to dedicate to the mentoring of trainees, a key component to successful mentoring.
描述(由应用程序提供):我的职业目标是继续担任以患者为导向的研究(POR)的研究者,并为初学者的研究人员提供心理。我的研究重点是住院患者,长期护理设施的居民和慢性血液透析群体中多药耐药生物(MDRO)的传播动态。我的研究已经确定了MDRO传播的关键和新颖方面,并量化了旨在减少其传播的最有效的预防策略。我的POR的方法包括大型队列和随机对照试验,MDRO菌株的基因分型和数学建模。在过去的几年中,我建立了一项成功的独立研究计划,并确保了国家卫生研究院(NIH),疾病控制与预防中心以及国家科学基金会的资助。在我的心态下,我还指导了许多研究员和初级教师,他们已经获得了自己的资金,该资金发表在领先的期刊上,并继续成为独立的调查员并获得了学术教师职位。由于我的研究跨越了几个学科,因此我指导了各种专科的学员,包括传染病肾脏病,老年医学和数学。这是我职业生涯中K24奖的最佳时期,因为我拥有一项积极的研究计划,该计划重点是在长期护理设施和门诊透析单元中开发和实施抗微生物管理计划。这项研究将使我为学员提供足够的机会进行研究。我最近还将研究领域扩展到了微生物组的分析以及鉴定增加MDRO获取风险的特定微生物特征,并最近与Martin Blaser(共同利用)研究员提交了R01,他们致力于在我的研究新领域中提供高级精神。 K24将为我花时间学习这个新领域所需的时间,以及我的研究议程的持续增长。最后,这款K24还将让我有保护的时间来献给受训者的心态,这是成功心态的关键组成部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIKA M D'AGATA其他文献
ERIKA M D'AGATA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIKA M D'AGATA', 18)}}的其他基金
The INFECTADO study: INFECTions Acquired by persons on maintenance hemoDialysis during hOspitalizations
INFECTADO 研究:住院期间接受维持性血液透析的人获得的感染
- 批准号:
10731626 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS)
优化维持性透析装置中的抗菌药物使用 (OPTIMUS)
- 批准号:
10161826 - 财政年份:2020
- 资助金额:
$ 17.65万 - 项目类别:
Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS)
优化维持性透析装置中的抗菌药物使用 (OPTIMUS)
- 批准号:
10641882 - 财政年份:2020
- 资助金额:
$ 17.65万 - 项目类别:
Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS)
优化维持性透析装置中的抗菌药物使用 (OPTIMUS)
- 批准号:
10436161 - 财政年份:2020
- 资助金额:
$ 17.65万 - 项目类别:
Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS)
优化维持性透析装置中的抗菌药物使用 (OPTIMUS)
- 批准号:
10816199 - 财政年份:2020
- 资助金额:
$ 17.65万 - 项目类别:
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
COBRE 抗菌素耐药性和治疗发现中心 - 行政核心
- 批准号:
10488622 - 财政年份:2018
- 资助金额:
$ 17.65万 - 项目类别:
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
COBRE 抗菌素耐药性和治疗发现中心
- 批准号:
10488596 - 财政年份:2018
- 资助金额:
$ 17.65万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented Research
以患者为导向的研究中的职业生涯中期研究员奖
- 批准号:
9235244 - 财政年份:2016
- 资助金额:
$ 17.65万 - 项目类别:
A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia
改善晚期痴呆症感染管理的随机对照试验试点研究
- 批准号:
8441316 - 财政年份:2013
- 资助金额:
$ 17.65万 - 项目类别:
A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia
改善晚期痴呆症感染管理的随机对照试验试点研究
- 批准号:
8676621 - 财政年份:2013
- 资助金额:
$ 17.65万 - 项目类别:
相似国自然基金
生态补奖背景下草原牧户实现自主性减畜的机制、路径和政策研究
- 批准号:72374130
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
草原生态补奖政策对牧户兼业行为的影响机理研究——以内蒙古为例
- 批准号:72363025
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:72104063
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
草原生态补奖政策激励-约束下牧民生产行为决策机制及生态效应
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:
相似海外基金
Evaluation of Cancer Health Activism Network for Greater Equity (CHANGE)
癌症健康行动网络的评估以实现更大的公平(变更)
- 批准号:
10665478 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Relationship Between Indoor Ultrafine Particle Exposure and Respiratory Morbidity, Inflammation, and Oxidative Stress in Children with Asthma
室内超细颗粒物暴露与哮喘儿童呼吸系统发病率、炎症和氧化应激之间的关系
- 批准号:
10470611 - 财政年份:2022
- 资助金额:
$ 17.65万 - 项目类别:
Aortic Dilatation in Endurance Athletes: A Physiologic and Mechanistic Study
耐力运动员的主动脉扩张:生理学和机制研究
- 批准号:
10681473 - 财政年份:2022
- 资助金额:
$ 17.65万 - 项目类别: